Back to Evidence Hub
Case Study S013
2017 Release

Noda 2017: PEP/LVET in Heart Failure

Noda et al.
Access Paper

Quick Conclusion: S013 provides a direct link between SCG metrics and advanced clinical interventions like CRT. It proves that the 'vibration-based' markers OpenSCG extracts have real diagnostic and therapeutic value in treating high-risk heart failure patients.


📊 Key Accuracy Metrics

MetricResult
FindingPEP/LVET ratio is a highly informative marker of cardiac performance
UtilityUseful for non-invasive optimization of CRT settings


🔍 Study Analysis

Objective & Population

Clinical Validation Study. Cohort: Patients with Heart Failure / Cardiac Resynchronization Therapy (CRT) (N=27).

What it Supports

The study supports the clinical value of measuring systolic time intervals (STI), specifically the ratio of pre-ejection period (PEP) to left ventricular ejection time (LVET), using non-invasive sensors. It demonstrates that these markers can help doctors optimize pacemaker (CRT) settings to improve heart function in heart failure patients.

What it Does Not Support

The study does not prove the technology is ready for unsupervised patient-led optimization at home without specialist oversight.


🛠 Technical Context

Study Snapshot

Metadata Summary

Target Population

Patients with Heart Failure / Cardiac Resynchronization Therapy (CRT)

N

Sample Size

27 Subjects

Validated Metric

PEP/LVET ratio is a highly informative marker of cardiac performance

Critical Appraisal
supporting

Validated the use of SCG-derived systolic time intervals for heart failure management.